Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TP53 and mutations in human cancer.

Katarzyna Szymańska1, Pierre Hainaut

  • 1Unit of Molecular Carcinogenesis, International Agency for Research on Cancer, Lyon, France.

Acta Biochimica Polonica
|April 4, 2003
PubMed
Summary

The tumor suppressor gene TP53 is frequently mutated in human cancers. Analyzing TP53 mutation patterns reveals mutagenic fingerprints, aiding in understanding cancer development and early detection via plasma DNA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing.

European journal of human genetics : EJHG·2026
Same author

The TP53 gene contains a diversity box that makes it more than a tumor suppressor.

Cell death and differentiation·2026
Same author

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.

EBioMedicine·2025
Same author

Transfer Learning for Survival-based Clustering of Predictors with an Application to <i>TP53</i> Mutation Annotation.

bioRxiv : the preprint server for biology·2025
Same author

Simultaneous exogenous application of trans-zeatin riboside and EDDS: A powerful strategy to improve heavy metals phytoextraction efficiency by Miscanthus x giganteus L.

Chemosphere·2025
Same author

A rare case of follicular thyroid carcinoma with unknown primary tumor location.

Nuclear medicine review. Central & Eastern Europe·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The TP53 gene is the most frequently mutated gene across human cancers, predominantly with missense mutations.
  • Specific mutation patterns within TP53 are observed in various cancers, influenced by mutagenesis and selection.
  • Geographic variations in TP53 mutation patterns suggest roles for region-specific risk factors in cancers like hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To analyze TP53 mutation patterns in human cancers to identify mutagenic fingerprints.
  • To explore the relationship between environmental factors, geographic location, and specific TP53 mutations.
  • To assess the potential of plasma DNA for detecting TP53 mutations for early cancer diagnosis.

Main Methods:

  • Analysis of TP53 gene mutation data from various human cancers.
  • Comparison of mutation patterns with known carcinogen effects (e.g., tobacco carcinogens).
  • Examination of geographic variations in mutation prevalence, particularly in HCC.
  • Investigation of TP53 mutation detection using cell-free DNA from plasma.

Main Results:

  • Organ-specific TP53 mutation patterns are evident in tobacco-related cancers (lung, head and neck).
  • Geographic variations in TP53 mutations are linked to incidence rates in cancers like esophageal squamous cell carcinoma and HCC.
  • A specific Ser-249 TP53 mutation is a striking example of a mutagen fingerprint in HCC from high-incidence regions.
  • Detection of TP53 mutations in plasma DNA is feasible, indicating potential for early cancer detection.

Conclusions:

  • TP53 mutation patterns serve as valuable indicators of mutagenic mechanisms in human cancer.
  • Environmental and geographic factors significantly shape cancer-specific TP53 mutation profiles.
  • Plasma-based detection of TP53 mutations offers a promising avenue for earlier and more accurate cancer diagnosis.

Related Experiment Videos